Kavitha Kotha

489 total citations
13 papers, 320 citations indexed

About

Kavitha Kotha is a scholar working on Pulmonary and Respiratory Medicine, Genetics and Physiology. According to data from OpenAlex, Kavitha Kotha has authored 13 papers receiving a total of 320 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 4 papers in Genetics and 4 papers in Physiology. Recurrent topics in Kavitha Kotha's work include Cystic Fibrosis Research Advances (4 papers), Neurogenetic and Muscular Disorders Research (3 papers) and Asthma and respiratory diseases (3 papers). Kavitha Kotha is often cited by papers focused on Cystic Fibrosis Research Advances (4 papers), Neurogenetic and Muscular Disorders Research (3 papers) and Asthma and respiratory diseases (3 papers). Kavitha Kotha collaborates with scholars based in United States and Türkiye. Kavitha Kotha's co-authors include Richard Shell, Grace Paul, John P. Clancy, Kathleen Church, Linda Lowes, Omar Dabbous, Douglas M. Sproule, B. Maru, Jerry R. Mendell and W. David Arnold and has published in prestigious journals such as PLoS ONE, Scientific Reports and CHEST Journal.

In The Last Decade

Kavitha Kotha

12 papers receiving 314 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kavitha Kotha United States	8	148	139	99	91	48	13	320
Shozo Oku Japan	10	101 0.7×	92 0.7×	104 1.1×	80 0.9×	40 0.8×	20	391
Andreas Thimm Germany	12	196 1.3×	134 1.0×	18 0.2×	62 0.7×	24 0.5×	21	277
Ricardo Reis Brazil	8	92 0.6×	136 1.0×	87 0.9×	20 0.2×	9 0.2×	15	291
Sheelagh Martin Canada	8	38 0.3×	55 0.4×	270 2.7×	72 0.8×	19 0.4×	10	370
Angeliki Balassopoulou Greece	10	53 0.4×	97 0.7×	161 1.6×	33 0.4×	59 1.2×	16	328
Marta Alonso Spain	8	94 0.6×	36 0.3×	39 0.4×	120 1.3×	52 1.1×	35	335
Vinay Kandula United States	8	53 0.4×	30 0.2×	31 0.3×	41 0.5×	26 0.5×	39	218
Dov Virgilis Israel	6	160 1.1×	28 0.2×	108 1.1×	32 0.4×	28 0.6×	9	301
Marina Flotats‐Bastardas Germany	7	57 0.4×	46 0.3×	20 0.2×	46 0.5×	23 0.5×	25	225
John Brewin United Kingdom	11	61 0.4×	176 1.3×	26 0.3×	49 0.5×	6 0.1×	33	307

Countries citing papers authored by Kavitha Kotha

Since Specialization

Citations

This map shows the geographic impact of Kavitha Kotha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kavitha Kotha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kavitha Kotha more than expected).

Fields of papers citing papers by Kavitha Kotha

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kavitha Kotha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kavitha Kotha. The network helps show where Kavitha Kotha may publish in the future.

Co-authorship network of co-authors of Kavitha Kotha

This figure shows the co-authorship network connecting the top 25 collaborators of Kavitha Kotha. A scholar is included among the top collaborators of Kavitha Kotha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kavitha Kotha. Kavitha Kotha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Sheikh, Shahid, et al.. (2025). Real-life impact of genotype and severity of lung disease on efficacy of elexacaftor-tezacaftor-ivacaftor in people with cystic fibrosis. Pulmonary Pharmacology & Therapeutics. 88. 102345–102345. 1 indexed citations

Bekircan‐Kurt, Can Ebru, Shoba Subramanian, M. Iammarino, et al.. (2025). Transitioning From Nusinersen to Risdiplam for Spinal Muscular Atrophy in Clinical Practice: A Single‐Center Experience. Muscle & Nerve. 71(3). 414–421. 3 indexed citations

Paul, Grace, Rami Khayat, Kavitha Kotha, et al.. (2021). A 17-Year-Old With Becker Muscular Dystrophy and Unusual Polysomnography Findings. CHEST Journal. 159(1). e19–e23.

Kotha, Kavitha, et al.. (2021). Food Insecurity Increased During the COVID-19 Pandemic in a Pediatric Cystic Fibrosis Population but Was Not Associated With Weight or Pulmonary Function. Current Developments in Nutrition. 5. 257–257. 1 indexed citations

Creary, Susan E., Chandra L. Shrestha, Kavitha Kotha, et al.. (2020). Baseline and Disease-Induced Transcriptional Profiles in Children with Sickle Cell Disease. Scientific Reports. 10(1). 9013–9013. 5 indexed citations

Paul, Grace, Courtney Gushue, Kavitha Kotha, & Richard Shell. (2020). The respiratory impact of novel therapies for spinal muscular atrophy. Pediatric Pulmonology. 56(4). 721–728. 23 indexed citations

Pickard, A. Simon, Kavitha Kotha, Lindsay N. Alfano, et al.. (2018). Health outcomes in spinal muscular atrophy type 1 following AVXS‐101 gene replacement therapy. Pediatric Pulmonology. 54(2). 179–185. 158 indexed citations

Sheikh, Shahid, et al.. (2016). Improved quality-of-life of caregivers of children with asthma through guideline-based management. Journal of Asthma. 54(7). 768–776. 14 indexed citations

Kotha, Kavitha, Rhonda D. Szczesniak, Anjaparavanda P. Naren, et al.. (2015). Concentration of fractional excretion of nitric oxide (FENO): A potential airway biomarker of restored CFTR function. Journal of Cystic Fibrosis. 14(6). 733–740. 14 indexed citations

10.

Kotha, Kavitha, et al.. (2015). Plastic Bronchitis Treated With Topical Tissue-Type Plasminogen Activator and Cryotherapy. Clinical Pediatrics. 55(12). 1171–1175. 8 indexed citations

11.

Sun, Hongtao, William T. Harris, Kavitha Kotha, et al.. (2014). TGF-Beta Downregulation of Distinct Chloride Channels in Cystic Fibrosis-Affected Epithelia. PLoS ONE. 9(9). e106842–e106842. 58 indexed citations

12.

Kotha, Kavitha & John P. Clancy. (2013). Ivacaftor treatment of cystic fibrosis patients with the G551D mutation: a review of the evidence. Therapeutic Advances in Respiratory Disease. 7(5). 288–296. 26 indexed citations

13.

Park, Youngja, Dean P. Jones, Thomas R. Ziegler, et al.. (2011). Metabolic effects of albumin therapy in acute lung injury measured by proton nuclear magnetic resonance spectroscopy of plasma: A pilot study*. Critical Care Medicine. 39(10). 2308–2313. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact